StockNews.com downgraded shares of Alimera Sciences (NASDAQ:ALIM – Free Report) from a buy rating to a hold rating in a research note issued to investors on Tuesday morning. Separately, Maxim Group started coverage on shares of Alimera Sciences in a research report on Monday, March 25th. They set a buy rating and a $10.00 price […]